🌱 KidneyEnergy.com

← brief for 2026-08-15 · Transplant & xeno

Short Perioperative Antiviral Prophylaxis for Hepatitis C Viremic Donor Kidney Transplantation: Outcomes in 204 Recipients

Paper B Peer reviewed Small trial

Key takeaways

A study of 204 kidney transplants using antiviral drugs to prevent hepatitis C-related damage. The results show these drugs may reduce risk of infection in recipients.

Who did this work

Fadel Dadabaev (Virginia Commonwealth University) · Idris Yakubu (Virginia Commonwealth University) · B. Agegnehu (Virginia Commonwealth University) · Vasco Pontinha (Virginia Commonwealth University) · Irfan Moinuddin (Virginia Commonwealth University) · A.M.S. Brown (Virginia Commonwealth University) · Sara Sterling (Virginia Commonwealth University) · A. Iaria (Virginia Commonwealth University) · Ryan Marks (Virginia Commonwealth University) · Taylor Sprague (Virginia Commonwealth University) · Dhiren Kumar (Virginia Commonwealth University) · Stephen R. Seelam (Virginia Commonwealth University)

Source

Paper · OpenAlex, Kidney disease concept sweep (verified C2778653478) · 2026-08-13
https://doi.org/10.1097/tp.0000000000005868